bluebird bio, Inc. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3aed2313-7c2b-4288-a82a-5399e24856fa/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-270.5M | 2024-01-01 – 2024-12-31 | evidence 0001293971-25-000009 |
| FY 2023 | $-244.3M | 2023-01-01 – 2023-12-31 | evidence 0001293971-24-000037 |
| FY 2022 | $-250.2M | 2022-01-01 – 2022-12-31 | evidence 0001293971-24-000037 |
| FY 2021 | $-590.9M | 2021-01-01 – 2021-12-31 | evidence 0001293971-22-000016 |
| FY 2020 | $-559.3M | 2020-01-01 – 2020-12-31 | evidence 0001293971-22-000016 |
| FY 2019 | $-563.0M | 2019-01-01 – 2019-12-31 | evidence 0001293971-22-000016 |
| FY 2018 | $-572.0M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-003694 |
| FY 2017 | $-332.2M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-002704 |
| FY 2016 | $-267.8M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002015 |
| FY 2015 | $-169.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013381 |
| FY 2014 | $-60.6M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-000948 |
| FY 2013 | $-24.9M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-084683 |
| FY 2012 | $-23.7M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-084683 |
| FY 2011 | $-15.1M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-084683 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).